Toxicity of spike fragments SARS-CoV-2 S protein for zebrafish: A tool to study its hazardous for human health?

Carregando...
Imagem de Miniatura
Citações na Scopus
19
Tipo de produção
article
Data de publicação
2022
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER
Autores
FEITOSA, Natalia Martins
BARBOSA, Ana Paula
BOMFIM, Camila Gasque
GARNIQUE, Anali M. B.
ROSA, Ivana F.
RODRIGUES, Maira S.
DORETTO, Lucas B.
COSTA, Daniel F.
CAMARGO-DOS-SANTOS, Bruno
Citação
SCIENCE OF THE TOTAL ENVIRONMENT, v.813, article ID 152345, 12p, 2022
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Despite the significant increase in the generation of SARS-CoV-2 contaminated domestic and hospital wastewater, little is known about the ecotoxicological effects of the virus or its structural components in freshwater vertebrates. In this context, this study evaluated the deleterious effects caused by SARS-CoV-2 Spike protein on the health of Danio rerio, zebrafish. We demonstrated, for the first time, that zebrafish injected with fragment 16 to 165 (rSpike), which corresponds to the N-terminal portion of the protein, presented mortalities and adverse effects on liver, kidney, ovary and brain tissues. The conserved genetic homology between zebrafish and humans might be one of the reasons for the intense toxic effects followed inflammatory reaction from the immune system of zebrafish to rSpike which provoked damage to organs in a similar pattern as happen in severe cases of COVID-19 in humans, and, resulted in 78,6% of survival rate in female adults during the first seven days. The application of spike protein in zebrafish was highly toxic that is suitable for future studies to gather valuable information about ecotoxicological impacts, as well as vaccine responses and therapeutic approaches in human medicine. Therefore, besides representing an important tool to assess the harmful effects of SARS-CoV-2 in the aquatic environment, we present the zebrafish as an animal model for translational COVID-19 research.
Palavras-chave
Coronavirus, Danio rerio, Environmental impacts, Infection diseases, Acute respiratory syndrome
Referências
  1. Abdel-Mannan O, 2020, JAMA NEUROL, V77, P1440, DOI 10.1001/jamaneurol.2020.2687
  2. Abu-Qdais HA, 2020, GLOB J ENVIRON SCI M, V6, P21, DOI 10.22034/GJESM.2019.06.SI.03
  3. Adhikari SP, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00646-x
  4. Bangaru S, 2020, SCIENCE, V370, P1089, DOI 10.1126/science.abe1502
  5. Beghi E, 2020, NEUROEPIDEMIOLOGY, V54, P364, DOI 10.1159/000508991
  6. Cavalcanti DD, 2020, AM J NEURORADIOL, V41, P1370, DOI 10.3174/ajnr.A6644
  7. Chou CF, 2006, GENE, V377, P46, DOI 10.1016/j.gene.2006.03.010
  8. Coughlan L, 2020, CELL HOST MICROBE, V28, P360, DOI 10.1016/j.chom.2020.08.007
  9. Cuervo NZ, 2020, ELIFE, V9, DOI 10.7554/eLife.61390
  10. Elsamadony M, 2021, SCI TOTAL ENVIRON, V755, DOI 10.1016/j.scitotenv.2020.142575
  11. Fan LJ, 2020, VET MICROBIOL, V251, DOI 10.1016/j.vetmic.2020.108905
  12. Faustino AI, 2017, SCI REP-UK, V7, DOI 10.1038/srep44329
  13. Gautam R, 2020, BRAIN BEHAV IMMUN, V88, P948, DOI 10.1016/j.bbi.2020.04.025
  14. Guzzo CR, 2009, J MOL BIOL, V393, P848, DOI 10.1016/j.jmb.2009.07.065
  15. Harrison AG, 2020, TRENDS IMMUNOL, V41, P1100, DOI 10.1016/j.it.2020.10.004
  16. Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052
  17. Iadecola C, 2020, CELL, V183, P16, DOI 10.1016/j.cell.2020.08.028
  18. Jiang RD, 2020, CELL, V182, P50, DOI 10.1016/j.cell.2020.05.027
  19. Jones DL, 2020, SCI TOTAL ENVIRON, V749, DOI 10.1016/j.scitotenv.2020.141364
  20. Jothimani D, 2020, J HEPATOL, V73, P1231, DOI 10.1016/j.jhep.2020.06.006
  21. Kampf G, 2020, J HOSP INFECT, V104, P246, DOI 10.1016/j.jhin.2020.01.022
  22. Keech C, 2020, NEW ENGL J MED, V383, P2320, DOI 10.1056/NEJMoa2026920
  23. Lan J, 2020, NATURE, V581, P215, DOI 10.1038/s41586-020-2180-5
  24. Lau KK, 2004, EMERG INFECT DIS, V10, P342, DOI 10.3201/eid1002.030638
  25. Liu DS, 2020, SCI TOTAL ENVIRON, V749, DOI 10.1016/j.scitotenv.2020.142358
  26. Lu YP, 2020, ECLINICALMEDICINE, V25, DOI 10.1016/j.eclinm.2020.100484
  27. McKibbin W, 2021, ASIAN ECON PAP, V20, P1, DOI 10.1162/asep_a_00796
  28. Meyerowitz EA, 2021, ANN INTERN MED, V174, P69, DOI 10.7326/M20-5008
  29. Moghadas SM, 2020, P NATL ACAD SCI USA, V117, P17513, DOI 10.1073/pnas.2008373117
  30. Moore JL, 2002, BIOTECHNIQUES, V32, P296, DOI 10.2144/02322st03
  31. Moura CD, 2016, BEHAV PROCESS, V128, P64, DOI 10.1016/j.beproc.2016.04.007
  32. Munz M, 2020, J NEUROL, V267, P2196, DOI 10.1007/s00415-020-09934-w
  33. Netland J, 2008, J VIROL, V82, P7264, DOI 10.1128/JVI.00737-08
  34. Nobrega RH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012808
  35. Qiu Y, 2020, MICROBES INFECT, V22, P221, DOI 10.1016/j.micinf.2020.03.003
  36. Ravichandran S, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.abc3539
  37. Reis FM, 2011, FERTIL STERIL, V95, P176, DOI 10.1016/j.fertnstert.2010.06.060
  38. Rhea EM, 2021, NAT NEUROSCI, V24, P368, DOI 10.1038/s41593-020-00771-8
  39. Samrat SK, 2020, VIRUS RES, V288, DOI 10.1016/j.virusres.2020.198141
  40. Sangkham S., 2020, CASE STUD CHEM ENV E, V2, DOI 10.1016/J.CSCEE.2020.100052
  41. Shang J, 2020, NATURE, V581, P221, DOI 10.1038/s41586-020-2179-y
  42. Sotoca J, 2020, NEUROL-NEUROIMMUNOL, V7, DOI 10.1212/NXI.0000000000000803
  43. Speedie N, 2008, BEHAV BRAIN RES, V188, P168, DOI 10.1016/j.bbr.2007.10.031
  44. Sun J, 2020, EMERG MICROBES INFEC, V9, P991, DOI 10.1080/22221751.2020.1760144
  45. Teymoorian T, 2021, J WATER PROCESS ENG, V42, DOI 10.1016/j.jwpe.2021.102193
  46. Tian SF, 2020, MODERN PATHOL, V33, P1007, DOI 10.1038/s41379-020-0536-x
  47. Tovo-Neto A, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10030429
  48. Tsang B, 2017, ZEBRAFISH, V14, P561, DOI 10.1089/zeb.2017.1477
  49. Urban RC, 2021, SCI TOTAL ENVIRON, V755, DOI 10.1016/j.scitotenv.2020.142471
  50. Vaz-Silva J, 2009, REPROD SCI, V16, P247, DOI 10.1177/1933719108327593
  51. Wang H, 2020, CELL, V182, P713, DOI 10.1016/j.cell.2020.06.008
  52. Wang J, 2020, ENVIRON POLLUT, V262, DOI 10.1016/j.envpol.2020.114665
  53. Wright EJ, 2008, NEUROL CLIN, V26, P617, DOI 10.1016/j.ncl.2008.03.006
  54. Xiao F, 2020, EMERG INFECT DIS, V26, P1920, DOI 10.3201/eid2608.200681
  55. Zand AD, 2020, RESOUR CONSERV RECY, V162, DOI 10.1016/j.resconrec.2020.105051
  56. Zupin L, 2020, J ASSIST REPROD GEN, V37, P2399, DOI 10.1007/s10815-020-01917-0